Next Article in Journal
Assessing Pharmacy Students’ and Preceptors’ Understanding of and Exposure to Antimicrobial Stewardship Practices on Introductory Pharmacy Practice Experiences
Next Article in Special Issue
Implementation of Smart Infusion Pumps: A Scoping Review and Case Study Discussion of the Evidence of the Role of the Pharmacist
Previous Article in Journal
The Consequences of General Medication Beliefs Measured by the Beliefs about Medicine Questionnaire on Medication Adherence: A Systematic Review
 
 
Article
Peer-Review Record

An Evaluation of the Impact of Barcode Patient and Medication Scanning on Nursing Workflow at a UK Teaching Hospital

Pharmacy 2020, 8(3), 148; https://doi.org/10.3390/pharmacy8030148
by Sara Barakat 1 and Bryony Dean Franklin 1,2,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Pharmacy 2020, 8(3), 148; https://doi.org/10.3390/pharmacy8030148
Submission received: 27 July 2020 / Revised: 10 August 2020 / Accepted: 15 August 2020 / Published: 19 August 2020

Round 1

Reviewer 1 Report

General comment

The authors report a small observational study evaluating whether barcode medication administration (BCMA) prolongs the length of time taken by nurses to administer medication. The study was well planned as a prior to an after BCMA introduction study, but was performed on two comparable surgical wards (gastrointestinal vs vascular surgery) with and without BCMA for time reasons.

The methodology, results and also the limitations of the study (short duration, small sample size) are adequately presented and addressed. This pilot study communicates that BCMA does not adversely affect the length of time taken by nurses to administer medication.

Specific comment

Line 154: Scanning a barcode sticker from the patient’s notes instead of the wristband. It should at least be discussed that in BCMA systems wristband scanning is obligatory, otherwise it does not reduced administration of a drug to a wrong patient.  

Line 253: It is well known that participation in a clinical study may produce better performance and results than in daily life. This phenomenon should be mentioned as possible bias, but it should not be mentioned as Hawthone effect. Otherwise the Hawthone effect should be explained. This is not easy. According to a systematic review there is no single, specific Hawthorne effect (McCambridge J, Witton J, Elbournec DR. Systematic review of the Hawthorne effect: New concepts are needed to study research participation effects. J Clin Epidemiol. 2014; 67: 267–277). Consequences of research participation for behaviors being investigated have been found to exist in most studies, although little can be securely known about the conditions under which they operate, their mechanisms of effects, or their magnitudes.

 

Author Response

Please see attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

Thank you for the submission. It is quite interesting and well-written, although not novel. The key limitations (e.g. different wards) are also mentioned.

Were the data checked appropriately for Normality?  Non-parametric statistical methods are probably more appropriate, given the large variability noted.

The mean number of drug doses administered differed substantially between the wards, which makes the absolute medication round time a very limited comparative measure. The most useful valid outcome is probably the difference in mean (or median?) time per dose - 4.2 minutes (range 3.3 to 5.5 min) on the non-BCMA ward and 2.3 minutes (range 1.8 to 3.2 min) on the BCMA ward (p< 0.001; t-test). While this is mentioned briefly, it is odd that this was not the primary outcome measure (and thereby standardising for the number of doses administered per round).

It would have been useful to also assess nurse satisfaction with the drug administration processes on each ward.

Author Response

Please see attachment

Author Response File: Author Response.pdf

Back to TopTop